Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Creatinine-to-body weight ratio as a marker of metabolic dysfunction and obesity-related steatosis in Egyptian patients
Egyptian Liver Journal
December 2026
Ebrahim S.
Open Access
Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study
BMC Gastroenterology
December 2026
Bagheri H.
Open Access
Diagnostic Performance of Non-Invasive Tests in Assessing Liver Fibrosis Among Type 2 Diabetes Mellitus
Acta Medica Indonesiana
28 September 2026
Mufida A.Z.
Comparative evaluation of noncontrast computed tomography (CT) histogram analysis, FibroScan, and serum markers for liver fibrosis assessment in chronic hepatitis B patients
Clinical Radiology
September 2026
İspiroğlu M.
Clinical utility of non-invasive markers in the assessment of liver fibrosis among type 2 diabetes mellitus patients
Turkish Journal of Biochemistry
1 August 2026
Weerarathna T.P.
Open Access
Comprehensive Approach to Detect Liver Fibrosis by Indirect Serum Biomarkers
Journal of Association of Physicians of India
August 2026
Garg H.
Assessment of non-invasive fibrosis scoring systems in pediatric MASLD: A retrospective comparison across healthy, MASLD, and biopsy-staged groups
Clinica Chimica Acta
15 April 2026
Bithi N.
Platelet Proteomics: A Glimpse Into Metabolic Dysfunction-Associated Steatotic Liver Disease Pathogenesis
Hepatology Research
April 2026
Minciuna I.
Open Access
Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease
BMC Gastroenterology
December 2025
Badran H.
Open Access
The Association of Fibrosis-4 (FIB 4) index with Chronic Kidney Disease Among Type 2 Diabetes Mellitus Patients with Concomitant Non-Alcoholic Fatty Liver Disease: A Single Center Cross-sectional Study
Phillippine Journal of Internal Medicine
April-June 2025
Pescador A.O.
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH
Liver International
December 2024
Martínez-Arenas L.
Open Access
The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy
Clinical and Experimental Nephrology
November 2024
Wei H.
Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease
Biomedicines
November 2024
de Abreu J.D.M.F.
Open Access
Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease
Journal of Clinical Medicine
November 2024
Ferraz-Amaro I.
Open Access
Alleviating Effect of Akkermansia muciniphila ONE on Hypercholesterolemia in Mice
Shipin Kexue Food Science
15 October 2024
Li Y.
Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients
Diabetes Metabolic Syndrome and Obesity
2024
Ding Y.
Open Access
Comparison of Fibrosis-4 with FibroScan for Liver Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease Patients: A Cross-sectional Study
Journal of the Dow University of Health Sciences
2024
Kakar F.
Open Access
Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes
Nutrition Metabolism and Cardiovascular Diseases
September 2023
Bódis K.
All Open Access, Green
Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis
Digestive Diseases
1 September 2023
Le M.H.
Open Access
FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning
Medicine United States
25 August 2023
Ding Y.
Open Access
Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection
Arab Journal of Gastroenterology
February 2023
Sefa Sayar M.
Predictive value of prothrombin time combined with Blatchford score for cirrhotic portal hypertension complicated with esophageal-gastric variceal re-bleeding
Revista De Psiquiatria Clinica
2023
Liu G.
Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
Marine Drugs
June 2022
Feng J.
Open Access
Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
World Journal of Hepatology
27 April 2022
Al Nadaf L.
Open Access
Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
Diagnostics
April 2022
Trifan A.
Open Access